Proceeds will be used to drive the commercial adoption of IBEX X-ray detectors in medical and industrial markets
IBEX Innovations Limited, the company behind a revolutionary X-ray detector that delivers safer, higher quality imaging in medical and industrial applications, announces today that it has completed a £1.9m funding round.
The funding was provided by new investors the Finance for Business North East Technology Fund (the NETF), managed by IP Group plc, and IP Group plc alongside an existing strategic investor. The funds will be used to enable IBEX to drive the commercial adoption of its X-ray detectors in both medical and industrial markets as well as for continued product development.
IBEX has already secured its first licence deal with a leading industrial X-ray inspection company and first products incorporating the IBEX technology are expected to enter the market later this year.
The Company is now focused on developing applications for other markets including medical imaging and food inspection where its technology has the potential to improve the detection of impurities and defects at significantly lower X-ray doses.
Dr Neil Loxley, Chief Executive of IBEX, commented: “We are delighted to welcome the NETF and IP Group plc as shareholders. Having the support of a FTSE 250 listed company gives us a real confidence boost to push forward and maximise the value of our technology in multiple markets. We are also very grateful for the continued support of our existing strategic investor, which I believe demonstrates the great progress made in translating our world-leading technology into market-ready products.”
Duncan Lowery, Senior Investment Manager at IP Group, said: “IBEX has demonstrated an opportunity to approach new markets with its existing technology. We believe the business has great potential due to the nature of the approach to a market pain combined with a seasoned management team. We are very pleased to be able to support the company through this next phase of development.”
For further information see the NETF press release here.
Curvebeam to integrate IBEX Trueview® scatter correction in the LineUp product
IBEX launches project to improve breast cancer diagnoses at reduced patient dose
IBEX’s partner in portable security inspection reports a sharp increase in business
IP Group investment in IBEX recognised as “JEREMIE-Funded Deal of the Decade”
Invitation to Tender for the Provision of a Dedicated High End Simulation Server